FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to a pharmaceutical composition containing botulinum toxin and hyaluronic acid for treating pain syndrome in legs and to a method of treating pain syndrome in legs.
EFFECT: invention provides a synergetic effect of the composition, increasing both the anti-inflammatory and analgesic activity by the effect of inflammation inhibition in the pain syndrome in the foot, such as the pain resulting from the plantar fasciitis, foot fasciitis, diabetes and gout.
19 cl, 2 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ACUTE TISSUE HYPERTENSION SYNDROME IN PHLEGMON OF FOOT | 2018 |
|
RU2683855C1 |
| COMBINATION OF FLUPIRTINE AND CYCLOBENZAPRINE FOR TREATMENT OF PAIN SYNDROMES | 2017 |
|
RU2680244C1 |
| METHOD FOR ANESTHESIA DURING THERAPEUTIC BLOCKADE FOR PLANTAR FASCIITIS | 2021 |
|
RU2782203C2 |
| BIOPREPARATIONS COMPOSITIONS FOR INTRAVESICAL INSTILLATION | 2015 |
|
RU2720991C2 |
| COMPOSITION FOR LOCAL APPLICATION FOR REDUCTION OR RELIEF OF PAIN SYNDROME | 2014 |
|
RU2580280C2 |
| METHOD OF TREATMENT OF RESISTANT PAIN IN THE MEDIAL AND PLANTAR AREAS OF THE HEEL REGION | 2022 |
|
RU2801602C1 |
| METHOD OF TREATING PAIN AFTER LIMB AMPUTATION | 2023 |
|
RU2823155C1 |
| METHOD FOR CONSERVATIVE MANAGEMENT OF PLANTAR FASCIITIS | 2013 |
|
RU2531946C1 |
| SUPPRESSION OF ALLODYNIA INDUCED BY BONE CANCER | 2019 |
|
RU2791640C2 |
| LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE | 2017 |
|
RU2741497C2 |
